This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

5 Stocks With Unusual Insider Buying

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Masimo

The last name to look at with some interesting insider buying is medical equipment and supplies player Masimo (MASI - Get Report). This is a global medical technology company that develops, manufactures and markets noninvasive patient monitoring products. Insiders are buying this stock into modest strength since shares are up just over 4% so far in 2012.

Masimo has a market cap of $1.12 billion and an enterprise value of $982 million. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 19.22 and a forward price-to-earnings of 14.7. Its estimated growth rate for this year is 7.6%, and for next year it's pegged at 17.7%. This is a cash-rich company, since the total cash position on its balance sheet is $128.85 million and its total debt is just $110,000.

The CEO and chairman of the board just bought 50,000 shares, or about $923,000 worth of stock, at $18.47 per share.

From a technical perspective, MASI is currently trading below its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending for the last two months, with shares dropping from a high of $24.28 to a recent low of $18.20 a share. During that move, shares of MASI have been mostly making lower highs and lower lows, which is bearish technical price action. That said, the stock has started to rebound during the past week, and it now looks ready to trigger a breakout trade.

If you're bullish on MASI, then I would look for long-biased trades once this stock breaks out above some near-term overhead resistance at $19.93 a share with high-volume. Look for volume that's near or above its three-month average action of 475,591 shares. If we get that move, then I would look to add to any long positions once MASI takes out its 50-day at $21.06 and its 200-day at $21.23 with volume. Target a spike back toward its next significant overhead resistance level at $22.62 to $24.28 a share.

I would simply avoid MASI or look for short-biased trades if it fails to trigger that breakout and then drops back below that major near-term support at $18.20 a share with high volume. If we get that action, then MASI could setup to move back below its 52-week low of $17.62 a share.

To see more stocks with notable insider buying like China Biologic Products (CBPO), Ecolab (ECL) and Yahoo! (YHOO), check out the Stocks With Big Insider Buying portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ZOLT $0.00 0.00%
HPQ $34.57 -1.00%
MASI $30.35 -1.00%
P $15.50 2.60%
REN $1.06 1.90%

Markets

DOW 18,202.99 -85.64 -0.47%
S&P 500 2,107.74 -9.65 -0.46%
NASDAQ 4,976.7810 -31.3150 -0.63%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs